Skip to main content

Vera Bradley Foundation for Breast Cancer Raises $1,513,713 for Breast Cancer Research

Written by Customer Service on . Posted in Public Companies.

FORT WAYNE, Ind., Sept. 17, 2023 (GLOBE NEWSWIRE) — The Vera Bradley Foundation for Breast Cancer (the “Foundation”) today announced a donation of $1,513,713 to support the Vera Bradley Foundation Center for Breast Cancer Research at the Indiana University School of Medicine (“IU School of Medicine”). With this gift, the Foundation has funded $40.1 million of breast cancer research to date. In 2022, the Foundation pledged an additional $12.5 million to the IU School of Medicine, bringing the non-profit’s total commitment to breast cancer research to $50 million.

The Foundation’s donation announcement was shared at the 29th annual Vera Bradley Foundation for Breast Cancer Classic (the “Classic”), which gathered guests, players, and volunteers from across the country to raise funds for breast cancer research. The multi-day Classic event, held in Vera Bradley’s hometown of Fort Wayne, Indiana, featured women’s golf tournaments, pickleball tournaments, a sponsor reception, and a Foundation Celebration event at Fort Wayne Country Club.

Funding from the Foundation has allowed the IU School of Medicine to amass the talent, technology, and resources needed to become an international leader in targeted breast cancer therapies, specifically for triple negative breast cancer. More than 35 members of the Vera Bradley Foundation Center for Breast Cancer Research team at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center (the “IU Cancer Center”) work collaboratively with laboratory, clinical, translational and population/prevention researchers in a multi-disciplinary approach. In 2019, the IU Cancer Center was designated a Comprehensive Cancer Center, the highest level of recognition awarded by the National Cancer Institute (“NCI”) for research excellence. The IU Cancer Center is the only cancer center in Indiana and one of only 56 Comprehensive Cancer Centers in the nation to hold the rigorously maintained NCI designation.

“For the past 30 years, the Vera Bradley Foundation for Breast Cancer has been steadfastly committed to raising funds for breast cancer research,” noted Stephanie Scheele, Executive Director of the Vera Bradley Foundation for Breast Cancer. “We have not wavered from our mission to passionately pursue a cure, and our partnership with the IU School of Medicine has resulted in amazing discoveries and improved outcomes for those affected by this disease. Hope lives here and hope will remain here until we find a cure.”

The Foundation’s next fundraising campaign, Turn the Town Pink, will take place during National Breast Cancer Awareness Month in October. For updates and more information about how to partner with the Foundation, visit verabradley.org and follow the Vera Bradley Foundation for Breast Cancer on Facebook and @verabradleyfoundation on Instagram.

ABOUT VERA BRADLEY FOUNDATION FOR BREAST CANCER
The Vera Bradley Foundation for Breast Cancer raises funds for breast cancer research to find a cure and to improve the lives of the many affected by this disease. The Foundation has contributed $40.1 million to the Vera Bradley Foundation Center for Breast Cancer Research at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center at the Indiana University School of Medicine. The Center is focused on developing and dramatically improving therapies for some of the most difficult-to-treat types of breast cancer. Funds are raised through special events, partner events, and individual donations. 

Press Contacts:

Stephanie Scheele, Executive Director
sscheele@verabradley.com		Anna Shelton, Foundation Communication Specialist
ashelton@verabradley.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.